Ambiq Micro (AMBQ) Registration Filing summary

Company overview and business model

• Designs ultra-low power semiconductor solutions for edge AI, targeting personal devices, medical/healthcare, industrial, and smart home/building markets.

• Proprietary SPOT platform enables 2–5x lower power consumption than traditional chips, with over 270 million devices powered and 42 million units shipped in 2024.

• Revenue is primarily from SoCs bundled with software, with expansion plans into application processors and dedicated AI chips.

• Operates a fabless model, relying on TSMC for wafer fabrication and third parties for assembly and testing.

Financial performance and metrics

• Net sales for 2024 were $76.1M (up 16% YoY); Q1 2025 net sales were $15.7M (up 3.4% YoY).

• Gross margin improved to 31.9% in 2024 (from 29.7% in 2023); Q1 2025 gross margin was 53.3% (up from 41.0% in Q1 2024).

• Net loss was $39.7M in 2024 and $8.3M in Q1 2025; accumulated deficit of $328.5M as of March 31, 2025.

• Cash and equivalents were $61.4M as of March 31, 2025; expects IPO proceeds to extend runway for at least 12 months.

• Significant customer concentration: top five customers accounted for 92% of 2024 net sales.

Use of proceeds and capital allocation

• Estimated net proceeds of $68.8M (or $79.9M if over-allotment is exercised) at $23.50/share midpoint.

• Proceeds intended for general corporate purposes: working capital, sales/marketing, product development, admin, and capex.

• May use a portion for acquisitions, but no current agreements.